Generative AI applications in healthcare and life sciences

A demand-driven innovation report from Woven Health Collective

Executive summary

  • Generative Artificial Intelligence (GenAI) is experiencing exponential growth across various industries, particularly in healthcare and life sciences, driven by its ability to scale operations, improve efficiency, and realize cost synergies.
  • Healthcare and life sciences have emerged as highly relevant industries for GenAI adoption with large interest and potential in exploring administrative and research-focused use cases to start.
  • Leading technology vendors are exploring ways to work with stakeholders across the industry to improve workflows and ultimately enhance patient care and outcomes.
  • While GenAI offers promising opportunities to transform health care delivery, stakeholders will face challenges that will require cross-industry collaboration and innovation.
FIGURE_GenAI-2023-2027

In a field in which an estimated 30% of the $4.3 trillion spent each year in the US adds little to no value, in which many tens of thousands of people die yearly from preventable mistakes, and in which access to care is fragmented and inequities are commonplace, it is natural to be enthusiastic about the potential for GenAI to improve quality, efficiency, equity, and patient experience.”

Dr. Robert Wachter, MD, Chair of the Department of Medicine, UCSF